ATXN8OS
Putative protein ATXN8OS
Also known as: AT8OS_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for ATXN8OS in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
200 residues, UniProt reviewed canonical sequence.
>P0DMR3|ATXN8OS
1 MPCPGAPCCS LVATGSRVPF SGLKEEEEED GEDDEEEEEE GFFQKVLTPL LSWLLSRRLW
61 LGPQCSKLPL PSCCRQPPPA GPPVEGDGWL KSFQRSRRMC FTSKSFRPEP DMLYAQKAKG
121 WQLTQDSGGW EVQDQCTRIW SKENLLALNT HSRRQKGKRE NKVCVSTWQK SRGDRTYSSM
181 ATTPSMTKIL EGCMYRKLKCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATXN8OS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATXN8OS as an antibody target. Whether an autoantibody or antibody against ATXN8OS could matter depends on whether native ATXN8OS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATXN8OS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATXN8OS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...